Annexon (ANNX) Net Equity Issued and Repurchased (2020 - 2026)
Annexon (ANNX) posted quarterly Net Equity Issued and Repurchased of $33.6 million for Q1 2026, up 135.0% quarter-over-quarter from $14.3 million in Q4 2025.
Annexon (ANNX) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Annexon's Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $33.6 million for Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $33.6 million; the TTM figure through Mar 2026 stood at $52.5 million (down 56.74% YoY), while the FY2025 annual figure was $28.5 million, down 35.8% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $33.6 million, up from $14.3 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $117.0 million in Q4 2023, with the low at $4.6 million in Q4 2024.
- The 4-year median for Net Equity Issued and Repurchased is $33.1 million (2024), against an average of $48.2 million.
- The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased sank 96.04% in 2024, then soared 208.57% in 2025.
- Annexon's Net Equity Issued and Repurchased stood at $117.0 million in 2023, then tumbled by 96.04% to $4.6 million in 2024, then jumped by 208.57% to $14.3 million in 2025, then surged by 135.0% to $33.6 million in 2026.
- Business Quant data shows ANNX's Net Equity Issued and Repurchased at $33.6 million in Q1 2026, $14.3 million in Q4 2025, and $4.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Annexon | 1.00 Bn | 1.00 Bn | - | 32.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.16 Mn |
| Jun 30, 2026 | 32.16 Mn |
| Mar 31, 2026 | 33.60 Mn |
| Mar 31, 2026 | 33.60 Mn |
| Dec 31, 2025 | 14.30 Mn |
| Dec 31, 2025 | 14.30 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Jun 30, 2024 | 116.80 Mn |
| Jun 30, 2024 | 116.80 Mn |
| Mar 31, 2024 | 33.13 Mn |
| Mar 31, 2024 | 33.13 Mn |
| Dec 31, 2023 | 117.00 Mn |
| Dec 31, 2023 | 117.00 Mn |
| Mar 31, 2023 | 18.00 Mn |
| Mar 31, 2023 | 18.00 Mn |
| Sep 30, 2020 | 15,000.00 |
| Sep 30, 2020 | 15,000.00 |
| Jun 30, 2020 | 96.80 Mn |
| Jun 30, 2020 | 96.80 Mn |